The pediatric mental health crisis: A call to action for pediatricians
FDA expands use of eculizumab to patients 6 years and up with generalized myasthenia gravis
Clinician quiz: AAP clinical practice guideline for treatment of children with obesity
Cingulate reports phase 3 safety data for CTx-1301 to treat ADHD in children, adolescents